Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Effect of 120mg Somatuline Autogel at Different Dose Intervals (28, 42 or 56 Days) in Patients With Acromegaly

This study has been completed.
Information provided by (Responsible Party):
Ipsen Identifier:
First received: March 7, 2007
Last updated: June 18, 2012
Last verified: June 2012